about
Genetically modified proteins: functional improvement and chimeragenesisTargeting the Wnt pathways for therapiesIdentification of human butyrylcholinesterase organophosphate-resistant variants through a novel mammalian enzyme functional screen.Optimization of enzyme parameters for fermentative production of biorenewable fuels and chemicals.Directed evolution of mammalian anti-apoptosis proteins by somatic hypermutation
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 December 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Technologies of directed protein evolution in vivo.
@en
Technologies of directed protein evolution in vivo.
@nl
type
label
Technologies of directed protein evolution in vivo.
@en
Technologies of directed protein evolution in vivo.
@nl
prefLabel
Technologies of directed protein evolution in vivo.
@en
Technologies of directed protein evolution in vivo.
@nl
P2860
P1476
Technologies of directed protein evolution in vivo
@en
P2093
Artem Blagodatski
P2860
P2888
P304
P356
10.1007/S00018-010-0610-5
P577
2010-12-29T00:00:00Z